Published in J Neurol Sci on October 01, 1989
Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet (1998) 3.71
Opioid overdose in a patient using a fentanyl patch during treatment with a warming blanket. Anesth Analg (2001) 2.39
[Thyroid function, activities of daily living and survival in extreme old age: the 'Leiden 85-plus Study']. Ned Tijdschr Geneeskd (2006) 2.11
C-reactive protein is a strong but nonspecific risk factor of fatal stroke in elderly persons. Arterioscler Thromb Vasc Biol (2000) 1.70
Reduced disorderliness of growth hormone release in biochemically inactive acromegaly after pituitary surgery. Eur J Endocrinol (1998) 1.56
Bezafibrate reduces heart rate and blood pressure in patients with hypertriglyceridemia. J Hypertens (2001) 1.51
A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation. J Clin Endocrinol Metab (2001) 1.51
Altered neuroregulation of GH secretion in viscerally obese premenopausal women. J Clin Endocrinol Metab (2001) 1.45
Blood flow velocity changes in migraine attacks--a transcranial Doppler study. Cephalalgia (1991) 1.42
[The immune system and Alzheimer's disease]. Tijdschr Psychiatr (2011) 1.38
Serotonin metabolism in migraine. Neurology (1989) 1.38
Inflammation and stroke: the Leiden 85-Plus Study . Stroke (2002) 1.29
Inhibition of exocytosis by intracellularly applied antibodies against a chromaffin granule-binding protein. Nature (1989) 1.25
On serotonin and migraine: a clinical and pharmacological review. Cephalalgia (1993) 1.23
Interaction of atherosclerosis and inflammation in elderly subjects with poor cognitive function. Neurology (2003) 1.15
beta-Adrenergic receptors contribute to hypoxaemia induced vasodilation in man. Br J Clin Pharmacol (1995) 1.14
The interaction of growth hormone releasing hormone with other hypothalamic hormones on the release of anterior pituitary hormones. Clin Endocrinol (Oxf) (1986) 1.12
Reduction of plasma leptin levels and loss of its circadian rhythmicity in hypocretin (orexin)-deficient narcoleptic humans. J Clin Endocrinol Metab (2002) 1.11
An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women. J Clin Endocrinol Metab (1996) 1.10
Recurrent hypoglycaemia caused by the insulin autoimmune syndrome: the first Dutch case. Neth J Med (1996) 1.10
Sex-dependent alteration in cortisol response to endogenous adrenocorticotropin. J Clin Endocrinol Metab (1993) 1.10
Familial longevity is associated with decreased thyroid function. J Clin Endocrinol Metab (2010) 1.09
Pharmacological studies on frozen stored canine saphenous veins and basilar arteries. Naunyn Schmiedebergs Arch Pharmacol (1986) 1.07
Low innate production of interleukin-1beta and interleukin-6 is associated with the absence of osteoarthritis in old age. Osteoarthritis Cartilage (2010) 1.06
Fluoxetine increases insulin action in obese nondiabetic and in obese non-insulin-dependent diabetic individuals. Int J Obes Relat Metab Disord (1992) 1.03
Does jejunal feeding activate exocrine pancreatic secretion? Eur J Clin Invest (1999) 1.02
Convergence of circadian and sleep regulatory mechanisms on hypocretin-1. Neuroscience (2004) 1.01
Preterm birth and later insulin resistance: effects of birth weight and postnatal growth in a population based longitudinal study from birth into adult life. Diabetologia (2006) 1.01
Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM. Diabetologia (1997) 1.00
Octreotide long-acting repeatable and lanreotide Autogel are equally effective in controlling growth hormone secretion in acromegalic patients. Eur J Endocrinol (2004) 1.00
Growth hormone (GH) secretion in patients with an inactivating defect of the GH-releasing hormone (GHRH) receptor is pulsatile: evidence for a role for non-GHRH inputs into the generation of GH pulses. J Clin Endocrinol Metab (2001) 0.99
Increased prevalence of catecholamine excess and phaeochromocytomas in a well-defined Dutch population with SDHD-linked head and neck paragangliomas. Eur J Endocrinol (2005) 0.97
Endotoxin, cytokines, and procalcitonin in febrile patients admitted to the hospital: identification of subjects at high risk of mortality. Clin Infect Dis (2000) 0.96
Reversal of the sex difference in serum leptin levels upon cross-sex hormone administration in transsexuals. J Clin Endocrinol Metab (1997) 0.96
The prevalence of subclinical hypothyroidism at different total plasma cholesterol levels in middle aged men and women: a need for case-finding? Clin Endocrinol (Oxf) (1999) 0.96
Quality of life in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomized controlled trial. Clin Endocrinol (Oxf) (2006) 0.95
Atrial natriuretic peptide improves pulmonary gas exchange in subjects exposed to hypoxia. Am Rev Respir Dis (1993) 0.95
Greater disorderliness of ACTH and cortisol release accompanies pituitary-dependent Cushing's disease. Eur J Endocrinol (1997) 0.94
Performance of the whole-blood stimulation assay for assessing innate immune activation under field conditions. Cytokine (2009) 0.94
Clinical and experimental effects of sumatriptan in humans. Trends Pharmacol Sci (1993) 0.93
Effect of insulin on basal and cholecystokinin-stimulated gallbladder motility in humans. J Hepatol (1998) 0.92
Characterization of the P2' and P3' specificities of thrombin using fluorescence-quenched substrates and mapping of the subsites by mutagenesis. Biochemistry (1996) 0.92
Reversible diastolic dysfunction after long-term exogenous subclinical hyperthyroidism: a randomized, placebo-controlled study. J Clin Endocrinol Metab (2005) 0.92
Diurnal secretion profiles of growth hormone, thyrotrophin and prolactin in Parkinson's disease. J Neuroendocrinol (2011) 0.90
Pulsatile LH release is diminished, whereas FSH secretion is normal, in hypocretin-deficient narcoleptic men. Am J Physiol Endocrinol Metab (2004) 0.89
High level expression of human apolipoprotein A-I in transgenic rats raises total serum high density lipoprotein cholesterol and lowers rat apolipoprotein A-I. Transgenic Res (1992) 0.89
Predictive value of tetrapolar body impedance measurements for hydration status in critically ill patients. Intensive Care Med (1995) 0.89
Parental history of Alzheimer disease associated with lower plasma apolipoprotein E levels. Neurology (2009) 0.89
Increased episodic release and disorderliness of prolactin secretion in both micro- and macroprolactinomas. Eur J Endocrinol (1999) 0.88
Amylin-induced in vivo insulin resistance in conscious rats: the liver is more sensitive to amylin than peripheral tissues. Diabetologia (1991) 0.88
Fluoxetine increases insulin action in obese type II (non-insulin dependent) diabetic patients. Int J Obes Relat Metab Disord (1992) 0.88
Effects of recombinant human leptin treatment as an adjunct of moderate energy restriction on body weight, resting energy expenditure and energy intake in obese humans. Diabetes Nutr Metab (2003) 0.88
Neuroexcitatory plasma amino acids are elevated in migraine. Neurology (1990) 0.88
Antenatal glucocorticoid treatment is not associated with long-term metabolic risks in individuals born before 32 weeks of gestation. Arch Dis Child Fetal Neonatal Ed (2008) 0.88
Cerebral blood flow during migraine attacks without aura and effect of sumatriptan. Arch Neurol (1995) 0.87
Contribution of partial pancreatectomy, systemic hormone delivery, and duct obliteration to glucose regulation in canine pancreas. Importance in pancreas transplantation. Diabetes (1989) 0.87
Cesarean section combined with splenectomy in a parturient with immune thrombocytopenic purpura. J Clin Anesth (2001) 0.87
Dose-dependent inhibition of postprandial gallbladder motility and plasma hormone secretion during acute hyperglycemia. Scand J Gastroenterol (1998) 0.86
Experiments on the preparation of blood components with the IBM 2991 blood cell processor. Vox Sang (1975) 0.86
Hypoxic syncope. Aviat Space Environ Med (1997) 0.86
Oral sumatriptan: effect of a second dose, and incidence and treatment of headache recurrences. Cephalalgia (1994) 0.86
Bromocriptine-induced trigeminal neuralgia attacks in a patient with a pituitary tumor. Neurology (1988) 0.86
Circadian rhythm of plasma leptin levels in upper and lower body obese women: influence of body fat distribution and weight loss. J Clin Endocrinol Metab (1998) 0.86
Nutritional status in anorexia nervosa: clinical chemistry, vitamins, iron and zinc. Eur J Clin Nutr (1988) 0.85
The effect of equicaloric medium-chain and long-chain triglycerides on pancreas enzyme secretion. Clin Physiol Funct Imaging (2002) 0.85
Serum uric acid correlates in elderly men and women with special reference to body composition and dietary intake (Dutch Nutrition Surveillance System). J Clin Epidemiol (1990) 0.85
Growth hormone secretion in recently operated acromegalic patients. J Clin Endocrinol Metab (1994) 0.85
Blood flow velocities in the vertebrobasilar system during migraine attacks--a transcranial Doppler study. Cephalalgia (1992) 0.84
Malignancy-associated hypercalcaemia: resolution of controversies over vitamin D metabolism by a pathophysiological approach to the syndrome. Clin Endocrinol (Oxf) (1994) 0.84
Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists. Thromb Haemost (1993) 0.84
Platelet preservation V. Survival, serotonin uptake velocity, and response to hypotonic stress of fresh and cryopreserved human platelets. Transfusion (1977) 0.84
Growth hormone and ghrelin secretion are associated with clinical severity in Huntington's disease. Eur J Neurol (2009) 0.84
Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in patients with adult-onset GH deficiency. J Clin Endocrinol Metab (1998) 0.84
Long-term results of transsphenoidal pituitary microsurgery in 60 acromegalic patients. Clin Endocrinol (Oxf) (1985) 0.83
Serum levels of unconjugated aetiocholanolone androstenedione, testosterone, dehydroepiandrosterone, aldosterone, progesterone and oestrogens during the normal menstrual cycle. Acta Endocrinol (Copenh) (1976) 0.83
Psychological and metabolic responses of carbohydrate craving obese patients to carbohydrate, fat and protein-rich meals. Int J Obes Relat Metab Disord (1997) 0.83
The effects of duct obliteration and of autotransplantation on the endocrine function of canine pancreatic segments. Diabetes (1985) 0.83
Endothelin-1 plasma concentration increases in the early phase of pulmonary hypertension development during respiratory distress syndrome: a study in newborn lambs. Early Hum Dev (2001) 0.83
A switch from oral (2 mg/day) to transdermal (50 microg/day) 17beta-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency. J Clin Endocrinol Metab (2000) 0.83
Alterations in calcium metabolism in young people at risk for primary hypertension. The Dutch Hypertension and Offspring Study. Hypertension (1993) 0.83
Prediction of the outcome of treatment of Paget's disease of bone with bisphosphonates from short-term changes in the rate of bone resorption. J Clin Endocrinol Metab (1996) 0.83
Increased insulin action and clearance in hyperthyroid newly diagnosed IDDM patient. Restoration to normal with antithyroid treatment. Diabetes Care (1989) 0.82
Impact of meal timing and frequency on the twenty-four-hour leptin rhythm. Horm Res (2004) 0.82
Steroid radiommuoassay: contribution of standards to blank values. Steroids (1974) 0.82
Functional studies on human veins after storage at--190 degrees C. Br J Pharmacol (1986) 0.82
Irregular and frequent cortisol secretory episodes with preserved diurnal rhythmicity in primary adrenal Cushing's syndrome. J Clin Endocrinol Metab (2004) 0.82
Endocrine functions in Huntington's disease. A two-and-a-half years follow-up study. J Neurol Sci (1989) 0.82
Combined amplification of the pulsatile and basal modes of adrenocorticotropin and cortisol secretion in patients with Cushing's disease: evidence for decreased responsiveness of the adrenal glands. J Clin Endocrinol Metab (1995) 0.82
Evidence for brain serotonin-mediated control of carbohydrate consumption in normal weight and obese humans. Int J Obes Relat Metab Disord (1993) 0.82
Weight changes in critically ill patients evaluated by fluid balances and impedance measurements. Crit Care Med (1993) 0.82
Glucose tolerance and lipid profile in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomised controlled trial. Clin Endocrinol (Oxf) (2006) 0.81
The influence of long-term treatment with cyproterone acetate or a cyproterone acetate-ethinyl oestradiol combination on androgen levels in blood of hirsute women. J Steroid Biochem (1980) 0.81
Effects of aspirin on serum C-reactive protein and interleukin-6 levels in patients with type 2 diabetes without cardiovascular disease: a randomized placebo-controlled crossover trial. Diabetes Obes Metab (2007) 0.81
Design, synthesis and biological evaluation of selective boron-containing thrombin inhibitors. Bioorg Med Chem (1999) 0.81
Glucagon-stimulated plasma C-peptide and insulin levels in active and non-active acromegalics. Clin Endocrinol (Oxf) (1985) 0.81
Lack of interaction between orlistat and oral contraceptives. Eur J Clin Pharmacol (1996) 0.81
Circulating atrial natriuretic peptide plasma levels as a marker for cardiac damage after radiotherapy. Radiother Oncol (2001) 0.81